BSYI (Biosyntech) OCF Margin %: -147,700.00% (As of Dec. 2009)


What is Biosyntech OCF Margin %?

Biosyntech BSYI OCF Margin % is -147,700.00% as of Dec. 2009.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Biosyntech's Cash Flow from Operations for the three months ended in Dec. 2009 was $-1.48 Mil. Biosyntech's Revenue for the three months ended in Dec. 2009 was $0.00 Mil. Therefore, Biosyntech's OCF Margin % for the quarter that ended in Dec. 2009 was -147,700.00%.

As of today, Biosyntech's current OCF Yield % is -687,500.00%.

The historical rank and industry rank for Biosyntech's OCF Margin % or its related term are showing as below:

BSYI' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -3798.34


BSYI's OCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -68.59 vs BSYI: -3798.34


Biosyntech OCF Margin % Related Terms


Biosyntech OCF Margin % Historical Data

* Premium members only.

The historical data trend for Biosyntech's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosyntech OCF Margin % Chart

Biosyntech Annual Data
Trend Mar00 Mar01 Mar02 Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,184.93 -9,879.63 -3,097.12 -3,063.00 -23,659.38

Biosyntech Quarterly Data
Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -57,100.00 -9,694.74 -3,463.27 -1,659.82 -147,700.00

BSYI vs NSPX, HSTC, PZRXQ: OCF Margin % Comparison

For the Biotechnology subindustry, Biosyntech's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosyntech OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosyntech's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Biosyntech's OCF Margin % falls into.



Biosyntech OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Biosyntech's OCF Margin for the fiscal year that ended in Mar. 2009 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2009 )/Revenue (A: Mar. 2009 )
=-7.571/0.032
=-23,659.38 %

Biosyntech's OCF Margin for the quarter that ended in Dec. 2009 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2009 )/Revenue (Q: Dec. 2009 )
=-1.477/0.001
=-147,700.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -147,700.00% mean?
Biosyntech (BSYI) has a OCF Margin % of -147,700.00% as of Dec. 2009. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Biosyntech and its competitors.
Is Biosyntech's OCF Margin % too high?
Biosyntech's current OCF Margin % is -147,700.00%.
How does Biosyntech's OCF Margin % compare to NSPX and HSTC?
Biosyntech's OCF Margin % of -147,700.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Biosyntech and its competitors. Biosyntech's current OCF Margin % is -147,700.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biosyntech stock overvalued right now?
Biosyntech (BSYI) has a current OCF Margin % of -147,700.00%. The current OCF Margin % is -147,700.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Biosyntech (BSYI), the current OCF Margin % is -147,700.00% as of Dec. 2009. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biosyntech Business Description

Address 475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3
Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.